Cambridge Scientists Pioneer Targeted Immune Therapy for Cancer
Researchers at the University of Cambridge have developed a new method to activate the immune system against cancer with greater precision and fewer side effects. The breakthrough focuses on the STING pathway, a cellular alarm system that signals the immune system to attack tumours. While existing drugs targeting STING have shown potential, their activation in
